Biocept, Inc.
BIOCQ · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | -$0 | $0 |
| % Growth | -12.5% | 106.5% | -1,121.4% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -332.9% | -349.9% | 141.9% | -473.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -494.9% | -963.4% | 176.6% | -946.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -616.5% | -1,061.5% | 180.1% | -1,005.5% |
| EPS Diluted | -3.5 | -12.16 | -32.732 | -17.87 |
| % Growth | 71.2% | 62.9% | -83.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |